Suraksha Diagnostic Ltd reports Q2 FY27 PAT of ₹14.95 crore, up 69% year-on-year
- Released unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026.
- Q2 total income rose 26% to ₹100.58 crore; EBITDA increased 45% to ₹36.32 crore, with a 36.7% margin.